Liver dysfunction associated with gold therapy for rheumatoid arthritis.
Hepatic toxicity is rarely associated with gold therapy. Three patients with rheumatoid arthritis who developed jaundice during the course of chrysotherapy are described. Jaundice occurred both early and late in the course of therapy. differing grades of severity of dysfunction were encountered. Liver biopsy revealed intrahepatic cholestasis. Significance of jaundice occurring during gold therapy is discussed.
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced*; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000187:drug effects; D008875:Middle Aged; D013997:Time Factors
D006052:Gold Sodium Thiomalate